CVS$88.521.92%-1.73
After Hours: 88.90+0.38 +0.43%
Cvs Health Corp (CVS)
Date: 2026-11-02 16:00O: 90.23H: 90.62L: 87.88C: 88.52Vol: 7.459M
Cvs Health Corp stock is traded at $88.52, with a volume of 7,459,377. It is down -1.92% in the last 24 hours and up +2.38% over the past month. CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Previous Close:
$90.25
Open:
$90.23
24h Volume:
7,459,377
Relative Volume:
1.10
Market Cap:
$113.21B
Revenue:
$407.94B
Net Income/Loss:
$2.90B
P/E Ratio:
38.87
EPS:
$2.28
Net Cash Flow:
$7.39B
1W Performance:
-4.33%
1M Performance:
+2.38%
6M Performance:
+7.83%
1Y Performance:
+13.27%
1-Day Range:
$87.88$90.62
1-Week Range:
$87.88$93.07
52-Week Range:
$69.51$110.68
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health CorpSector
HealthcareIndustry
Healthcare PlansPhone
(401) 765-1500Address
ONE CVS DR., WOONSOCKET, USACompare CVS vs UNH, ELV, CI, HUM
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
CVS Cvs Health Corp | $113.21B | $415.09B | $4.89B | $11.76B | $2.28 |
 UNH Unitedhealth Group Inc | $359.42B | $450.13B | $14.12B | $23.62B | $15.55 |
 ELV Elevance Health Inc | $89.73B | $201.83B | $5.14B | $6.51B | $22.50 |
 CI Cigna Group | $77.99B | $282.38B | $6.42B | $8.44B | $23.60 |
 HUM Humana Inc | $49.28B | $137.20B | $1.13B | $1.27B | $9.34 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Cvs Health Corp Stock (CVS) Financials Data
Cvs Health Corp Stock (CVS) Insider Trading
- FARAH ROGER NMay 21 '26Director
- Transaction
- Proposed Sale
- Cost
- $93.68
- #Shares
- 2,817
- Value ($)
- 263,886
- #Shares Total
- 0
- ROBBINS LARRYMay 21 '26Director
- Transaction
- Sale
- Cost
- $93.45
- #Shares
- 370,462
- Value ($)
- 34,619,007
- #Shares Total
- 4,824,799
- AGUIRRE FERNANDOMay 20 '26Director
- Transaction
- Proposed Sale
- Cost
- $94.69
- #Shares
- 2,263
- Value ($)
- 214,283
- #Shares Total
- 0
- ROBBINS LARRYMay 20 '26Director
- Transaction
- Sale
- Cost
- $93.82
- #Shares
- 1,018,000
- Value ($)
- 95,510,822
- #Shares Total
- 5,195,261
- ROBBINS LARRYMay 19 '26Director
- Transaction
- Sale
- Cost
- $94.45
- #Shares
- 1,983,538
- Value ($)
- 187,341,308
- #Shares Total
- 6,213,261
- Mandadi TilakMay 08 '26EVP, Chief Exp & Tech Officer
- Transaction
- Sale
- Cost
- $89.58
- #Shares
- 69,551
- Value ($)
- 6,230,379
- #Shares Total
- 10,133
- TILAK MANDADIMay 08 '26Officer
- Transaction
- Proposed Sale
- Cost
- $89.58
- #Shares
- 69,551
- Value ($)
- 6,230,719
- #Shares Total
- 0
